Back to Search
Start Over
Comparison of a robotic surgery program for rectal cancer: short- and long-term results from a comparative, retrospective study between two laparoscopic and robotic reference centers.
- Source :
- Surgical Endoscopy & Other Interventional Techniques; Jul2024, Vol. 38 Issue 7, p3738-3757, 20p
- Publication Year :
- 2024
-
Abstract
- Background: It is assumed that robotic-assisted surgery (RAS) may facilitate complex pelvic dissection for rectal cancer compared to the laparoscopic-assisted resection (LAR). The aim of this study was to compare perioperative morbidity, short- and long-term oncologic, and functional outcomes between the RAS and LAR approaches. Methods: Between 2015 and 2021, all rectal cancers operated on by (LAR) or (RAS) were retrospectively reviewed in two colorectal surgery centers. Results: A total of 197 patients were included in the study, with 70% in the LAR group and 30% in the RAS group. The tumor location and stage were identical in both groups (not significant = NS). The overall postoperative mortality rate was not significantly different between the two groups. (0% LAR; 0.5% RAS; NS). The postoperative morbidity was similar between the two groups (60% LAR vs 57% RAS; NS). The number of early surgical re-interventions within the first 30 days was similar (10% for the LAR group and 3% for the RAS group; NS). The rate of complete TME was similar (88% for the LAR group and 94% for the RAS group; NS). However, the rate of circumferential R1 was significantly higher in the LAR group (13%) compared to the RAS group (2%) (p = 0.009). The 3-year recurrence rate did not differ between the two groups (77% for both groups; NS). After a mean follow-up of three years, the incidence of anterior resection syndrome was significantly lower in the LAR group compared to the RAS group (54 vs 76%; p = 0.030). Conclusions: The use of a RAS was found to be reliable for oncologic outcomes and morbidity. However, the expected benefits for functional outcomes were not observed. Therefore, the added value of RAS for rectal cancer needs to be reassessed in light of new laparoscopic technologies and patient management options. [ABSTRACT FROM AUTHOR]
- Subjects :
- SURGICAL robots
CANCER treatment
T-test (Statistics)
LAPAROSCOPIC surgery
QUESTIONNAIRES
FISHER exact test
FUNCTIONAL status
TREATMENT effectiveness
RETROSPECTIVE studies
DESCRIPTIVE statistics
MINIMALLY invasive procedures
HEALTH surveys
CHI-squared test
MANN Whitney U Test
RECTUM tumors
DISEASES
SURGICAL complications
QUALITY of life
DEFECATION disorders
ANALYSIS of variance
COMPARATIVE studies
TUMOR classification
LENGTH of stay in hospitals
PERIOPERATIVE care
SPECIALTY hospitals
Subjects
Details
- Language :
- English
- ISSN :
- 18666817
- Volume :
- 38
- Issue :
- 7
- Database :
- Complementary Index
- Journal :
- Surgical Endoscopy & Other Interventional Techniques
- Publication Type :
- Academic Journal
- Accession number :
- 178230375
- Full Text :
- https://doi.org/10.1007/s00464-024-10867-y